PMCB / PharmaCyte Biotech, Inc. - Net Long/Short Value

PharmaCyte Biotech, Inc.
US ˙ NasdaqCM ˙ US71715X2036

PMCB / PharmaCyte Biotech, Inc. - Net Long/Short Value
Auf dieser Seite finden Sie die Netto-Long/Short-Bewertungen für jede institutionelle Beteiligung, die über die 13F- oder NPORT-Berichte gemeldet wurde. Um den Netto-Long/Short-Wert zu berechnen, addieren wir den Aktienwert zum Wert der Call-Option und ziehen den Wert der Put-Option ab. Fonds, die geliehene Short-Positionen melden, weisen den Aktienwert als negativ aus. Netto-Long-Positionen haben positive Zahlen in der Netto-Long/Short-Spalte, und Netto-Short-Positionen haben negative Werte in dieser Spalte.
Besitzer Eigenkapitalwert
($1000)
Call Wert
($1000)
Put Wert
($1000)
Net Long/Short
($1000)
Johnson Financial Group, Inc.
Northern Trust Corp
Huntington National Bank
Covestor Ltd
Abound Wealth Management
Geode Capital Management, Llc
Hrt Financial Lp
MCF Advisors LLC
Vanguard Capital Management Llc
BlackRock, Inc.
Financial Consulate, Inc
Simplex Trading, Llc
Ground Swell Capital, LLC
Renaissance Technologies Llc
Morgan Stanley
UBS Group AG
Harbour Investments, Inc.
Cwm, Llc
XTX Topco Ltd
Sachetta, LLC
Vanguard Fiduciary Trust Co
Schonfeld Strategic Advisors LLC
Equitec Proprietary Markets, Llc
SBI Securities Co., Ltd.
Two Sigma Securities, Llc
Tower Research Capital LLC (TRC)
Citadel Advisors Llc
Advisor Group Holdings, Inc.
Caldwell Securities, Inc
Fortitude Family Office, LLC
Virtu Financial LLC
Jane Street Group, Llc
Western Wealth Management, LLC
Vanguard Group Inc
Bfsg, Llc
How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista